| ［1］ |
Snekvik I, Nilsen T, Romundstad PR, et al. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT study, Norway［J］. Br J Dermatol, 2019,180（1）:94⁃99. doi: 10.1111/bjd.16885.
|
| ［2］ |
Shreberk⁃Hassidim R, Galili E, Hassidim A, et al. Epidemiology and comorbidities of psoriasis among Israeli adolescents: a large cross⁃sectional study［J］. Dermatology, 2019,235（6）:488⁃494. doi: 10.1159/000501032.
|
| ［3］ |
Aune D, Snekvik I, Schlesinger S, et al. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose⁃response meta⁃analysis of prospective studies［J］. Eur J Epidemiol, 2018,33（12）:1163⁃1178. doi: 10.1007/s10654⁃018⁃0366⁃z.
|
| ［4］ |
Kunz M, Simon JC, Saalbach A. Psoriasis: obesity and fatty acids［J］. Front Immunol, 2019,10:1807. doi: 10.3389/fimmu.2019. 01807.
|
| ［5］ |
Tupikowska⁃Marzec M, Kolačkov K, Zdrojowy⁃Wełna A, et al. The influence of FTO polymorphism rs9939609 on obesity, some clinical features, and disturbance of carbohydrate metabolism in patients with psoriasis［J］. Biomed Res Int, 2019,2019:7304345. doi: 10.1155/2019/7304345.
|
| ［6］ |
Loft ND, Skov L, Rasmussen MK, et al. Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis［J］. PLoS One, 2018,13（2）:e0192010. doi: 10.1371/journal.pone.0192010.
|
| ［7］ |
Yu GI, Ha E, Park SH, et al. Association of tumor necrosis factor⁃α （TNF⁃α） promoter polymorphisms with overweight/obesity in a Korean population［J］. Inflamm Res, 2011,60（12）:1099⁃1105. doi: 10.1007/s00011⁃011⁃0372⁃z.
|
| ［8］ |
Shiao S, Xiao H, Dong L, et al. Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non⁃obese controls ⁃ a preliminary report［J］. Oncotarget, 2018,9（39）:25557⁃25571. doi: 10.18632/oncotarget.25374.
|
| ［9］ |
Hodeib AA, Neinaa Y, Zakaria SS, et al. Glucose transporter⁃1 （GLUT⁃1） expression in psoriasis: correlation with disease severity［J］. Int J Dermatol, 2018,57（8）:943⁃951. doi: 10.1111/ijd.14037.
|
| ［10］ |
Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment［J］. J Dermatol, 2018,45（3）:264⁃272. doi: 10.1111/1346⁃8138.14139.
|
| ［11］ |
Francisco V, Pino J, Campos⁃Cabaleiro V, et al. Obesity, Fat mass and immune system: role for leptin［J］. Front Physiol, 2018,9:640. doi: 10.3389/fphys.2018.00640.
|
| ［12］ |
Zhang Y, Yuan H, Bu P, et al. Recombinant leptin attenuates abdominal aortic aneurysm formation in angiotensin II⁃infused apolipoprotein E⁃deficient mice［J］. Biochem Biophys Res Commun, 2018,503（3）:1450⁃1456. doi: 10.1016/j.bbrc.2018.07. 062.
|
| ［13］ |
Han JH, Lee JH, Han KD, et al. Increased risk of psoriasis in subjects with abdominal obesity: a nationwide population⁃based study［J］. J Dermatol, 2019,46（8）:695⁃701. doi: 10.1111/1346⁃8138.14939.
|
| ［14］ |
Bavoso NC, Pinto JM, Soares M, et al. Psoriasis in |
